Skip to content

Transversus Abdominis Plane Block and Inguinal Hernia Repair

The Analgesic Efficacy of the Ultrasound Guided Transversus Abdominis Plane Block After Inguinal Hernia Repair With a Mesh.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02030223
Enrollment
59
Registered
2014-01-08
Start date
2014-01-31
Completion date
2017-12-31
Last updated
2018-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Wall Muscles, Inguinal Hernia, Postoperative Pain, Regional Anesthesia

Keywords

transversus abdominis plane block, inguinal hernia repair, acute postoperative pain, neuropathic pain

Brief summary

This prospective, randomized, double blinded, placebo-controlled study is designed to evaluate the postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane block with ropivacaine 0,75 %, in patients undergoing unilateral inguinal hernia repair with a mesh under general anaesthesia, and how the efficiency of early postoperative analgesia achieved correlates with the risk of developing a chronic pain state, a not uncommon condition after this type of surgery.

Interventions

PROCEDURETransversus abdominis plane block

ultrasound guided transversus abdominis plane block

Sponsors

Papacharalampous Panagiota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

ASA I-III patients undergoing inguinal hernia repair with a mesh age between 18 and 75 years old ability to read and write greek \-

Exclusion criteria

* Inability to consent to the study * BMI \>40kg/m2 * Skin infection at the puncture site * Contraindication to mono-amide local anaesthetics, paracetamol, NSAID's (parecoxib) * Preoperative use of opioids or NSAID's for chronic pain conditions

Design outcomes

Primary

MeasureTime frame
Pain scores at rest and with movement using the numerical rating scale (NRS)3, 6 and 24 hours postoperatively

Secondary

MeasureTime frame
Incidence of chronic pain6 months after surgery

Other

MeasureTime frame
Morphine consumption (mg)24 hours postoperatively

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026